FDA Approved Products

6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

ENLON-PLUS
atropine sulfate; edrophonium chloride
LOE Approaching
INJECTION · INJECTABLE
older for: Atropine is an anticholinergic agent indicated in adultsolder for: Cycloplegia () Mydriasis () Penalization of the healthy eye in the treatment of amblyopia () 1
1991
NDA
30/100
ENOVID
mestranol; norethynodrel
LOE Approaching
Pfizer
ORAL · TABLET
1961
NDA
30/100
ENOVID-E
mestranol; norethynodrel
LOE Approaching
Pfizer
ORAL-20 · TABLET
1961
NDA
30/100
ENOVID-E 21
mestranol; norethynodrel
LOE Approaching
Pfizer
ORAL-21 · TABLET
1961
NDA
30/100
ENTADFI
finasteride; tadalafil
Peak
ORAL · CAPSULE
2021
NDA
30/100
ENTERO VU 24%
barium sulfate
Peak
Bracco
ORAL · SUSPENSION
2016
NDA
30/100
ENTOCORT EC
budesonide
LOE Approaching
Design Pharmaceuticals
ORAL · CAPSULE, DELAYED RELEASE
mild to moderate active Crohn's disease involving the ileum and/or the ascending colon in patients 8 years of ageolder+2
2001
NDA
30/100
EOVIST
gadoxetate disodium
LOE Approaching
Bayer
INTRAVENOUS · SOLUTION
2008
NDA
30/100
EPHEDRINE SULFATE
ephedrine sulfate
Peak
INTRAVENOUS · SOLUTION
clinically important hypotension occurring in the setting of anesthesia
2017
NDA
30/100
EPI E Z PEN JR
epinephrine
LOE Approaching
Viatris (2)
INTRAMUSCULAR · INJECTABLE
the emergency treatment of allergic reactions (Type I) including anaphylaxis
1987
NDA
30/100
EPIDUO FORTE
adapalene and benzoyl peroxide
Peak
Galderma
TOPICAL · GEL
2015
NDA
30/100
EPINEPHRINE
epinephrine
Peak
Pfizer
INTRAVENOUS · SOLUTION
regional anesthesiaanalgesia for surgery+5
2019
NDA
30/100
EPINEPHRINE
epinephrine
Peak
Medica Corp
INTRAVENOUS · SOLUTION
2022
NDA
30/100
EPINEPHRINE
epinephrine
Peak
INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS · SOLUTION
To increase mean arterial blood pressure
2014
NDA
30/100
EPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
epinephrine
Growth
Baxter
INTRAVENOUS · SOLUTION
2025
NDA
30/100
EPIPEN
epinephrine
LOE Approaching
Viatris (2)
INTRAMUSCULAR, SUBCUTANEOUS · INJECTABLE
the emergency treatment of allergic reactions (Type I) including anaphylaxis
1987
NDA
30/100
EPIPEN E Z PEN
epinephrine
LOE Approaching
Viatris (2)
INTRAMUSCULAR · INJECTABLE
the emergency treatment of allergic reactions (Type I) including anaphylaxis
1987
NDA
30/100
EPIPEN JR.
epinephrine
LOE Approaching
Viatris (2)
INTRAMUSCULAR, SUBCUTANEOUS · INJECTABLE
the emergency treatment of allergic reactions (Type I) including anaphylaxis
1987
NDA
30/100
EPIRUBICIN HYDROCHLORIDE
epirubicin hydrochloride
LOE Approaching
Pfizer
INTRAVENOUS · POWDER
breast cancer
2006
NDA
30/100
EPIVIR
lamivudine
LOE Approaching
GSK
ORAL · SOLUTION
combination with other antiretroviral agents for the treatment of HIV‑1 infection
1995
NDA
30/100
EPIVIR
lamivudine
LOE Approaching
GSK
ORAL · TABLET
combination with other antiretroviral agents for the treatment of HIV‑1 infection
1995
NDA
30/100
EPIVIR-HBV
lamivudine
LOE Approaching
GSK
ORAL · SOLUTION
HIV-1 infection in adultsweighing at least 6 kg
1998
NDA
30/100
EPIVIR-HBV
lamivudine
LOE Approaching
GSK
ORAL · TABLET
HIV-1 infection in adultsweighing at least 6 kg
1998
NDA
30/100
EPZICOM
abacavir sulfate; lamivudine
LOE Approaching
GSK
ORAL · TABLET
HIV-1 infection
2004
NDA
30/100
← PreviousPage 65 of 277Next →